Cargando…

Serelaxin Alleviates Fibrosis in Thyroid-Associated Ophthalmopathy via the Notch Pathway

Fibrosis is the late stage of thyroid-associated ophthalmopathy (TAO), resulting in serious complications. Effective therapeutic drugs are still lacking. We aimed to explore the mechanism of TAO fibrosis and to find a targeted drug. High-throughput RNA sequencing was performed on orbital connective...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sun, Anqi, Ye, Huijing, Xu, Zhihui, Chen, Jingqiao, Xiao, Wei, Zhang, Te, Sha, Xiaotong, Bi, Shaowei, Zhou, Tianyi, Yang, Huasheng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10179109/ https://www.ncbi.nlm.nih.gov/pubmed/37176063 http://dx.doi.org/10.3390/ijms24098356

Ejemplares similares

Metformin Attenuates Inflammation and Fibrosis in Thyroid-Associated Ophthalmopathy
por: Xu, Zhihui, et al.
Publicado: (2022)

Differential Circular RNA Expression Profiling of Orbital Connective Tissue From Patients With Type I and Type II Thyroid-Associated Ophthalmopathy
por: Ye, Huijing, et al.
Publicado: (2022)

Dihydroartemisinin Exerts Antifibrotic and Anti-Inflammatory Effects in Graves’ Ophthalmopathy by Targeting Orbital Fibroblasts
por: Yang, Shenglan, et al.
Publicado: (2022)

Clinical characteristics of moderate-to-severe thyroid associated ophthalmopathy in 354 Chinese cases
por: Li, Qian, et al.
Publicado: (2017)

Serelaxin alleviates cardiac fibrosis through inhibiting endothelial-to-mesenchymal transition via RXFP1
por: Wilhelmi, Tim, et al.
Publicado: (2020)

Head and Eye Trauma Before Retinoblastoma Diagnosis
por: Chen, Rongxin, et al.
Publicado: (2019)

Elevated Immunoglobulin G4 Levels in Patients with Thyroid Eye Disease and Their Clinical Implications
por: Ye, Huijing, et al.
Publicado: (2020)

Serelaxin increases the antifibrotic action of rosiglitazone in a model of hepatic fibrosis
por: Bennett, Robert G, et al.
Publicado: (2017)

Thyroid-associated Ophthalmopathy
por: Şahlı, Esra, et al.
Publicado: (2017)

Increased Dysfunctional and Plastic Regulatory T Cells in Idiopathic Orbital Inflammation
por: Chen, Jingqiao, et al.
Publicado: (2021)

Cytokines in Thyroid-Associated Ophthalmopathy
por: Zhang, Pengbo, et al.
Publicado: (2022)

Differences in the renal antifibrotic signaling of serelaxin and zaprinast
por: Wetzl, Veronika, et al.
Publicado: (2015)

The Therapeutic Effect of Combination of Orbital Decompression Surgery and Methylprednisolone Pulse Therapy on Patients with Bilateral Dysthyroid Optic Neuropathy
por: Xu, Jianan, et al.
Publicado: (2020)

IL-11 Is Elevated and Drives the Profibrotic Phenotype Transition of Orbital Fibroblasts in Thyroid-Associated Ophthalmopathy
por: Wu, Pengsen, et al.
Publicado: (2022)

MiRNA-21 promotes fibrosis in orbital fibroblasts from thyroid-associated ophthalmopathy
por: Bo-ding, Tong, et al.
Publicado: (2015)

Disulfiram Exerts Antifibrotic and Anti-Inflammatory Therapeutic Effects on Perimysial Orbital Fibroblasts in Graves’ Orbitopathy
por: Wang, Xing, et al.
Publicado: (2022)

Thyroid antibody-negative euthyroid Graves’ ophthalmopathy
por: Tabasum, Arshiya, et al.
Publicado: (2016)

The involvement of T cell pathogenesis in thyroid-associated ophthalmopathy
por: Huang, Yazhuo, et al.
Publicado: (2018)

Intraorbital Electroacupuncture Therapy for Thyroid-associated Ophthalmopathy
por: Zhou, Ling-Yun, et al.
Publicado: (2017)

Intraorbital Steroid Injection for Active Thyroid Ophthalmopathy
por: Bagheri, Abbas, et al.
Publicado: (2020)

Treating Thyroid Associated Ophthalmopathy in Pediatric Patients
por: Dong, Tianyu, et al.
Publicado: (2022)

Long-term follow-up of seven patients with ophthalmopathy not associated with thyroid autoimmunity: heterogeneity of autoimmune ophthalmopathy
por: McCorquodale, Tom, et al.
Publicado: (2012)

Outcome of thyroid associated ophthalmopathy treated by radiation therapy
por: Abboud, Mirna, et al.
Publicado: (2011)

Diagnosis, Follow-Up and Treatment Results in Thyroid Ophthalmopathy
por: Savku, Esra, et al.
Publicado: (2015)

Cutting‐edge endonasal surgical approaches to thyroid ophthalmopathy
por: Tyler, Matthew A., et al.
Publicado: (2018)

Clinical outcomes of hypofractionated radiotherapy for thyroid-associated ophthalmopathy
por: Lee, Sang Min, et al.
Publicado: (2020)

Teprotumumab as a Novel Therapy for Thyroid-Associated Ophthalmopathy
por: Smith, Terry J.
Publicado: (2020)

Effect of teprotumumab on intraocular pressure in thyroid-associated ophthalmopathy
por: Adetunji, Modupe O., et al.
Publicado: (2022)

The significance of ophthalmological features in diagnosis of thyroid-associated ophthalmopathy
por: Huang, Xiao, et al.
Publicado: (2023)

The early diagnostic value of optical coherence tomography (OCT) and OCT angiography in thyroid-associated ophthalmopathy
por: Xu, Bei, et al.
Publicado: (2023)

Serelaxin Elicits Bronchodilation and Enhances β-Adrenoceptor-Mediated Airway Relaxation
por: Lam, Maggie, et al.
Publicado: (2016)

Serelaxin improves cardiac and renal function in DOCA-salt hypertensive rats
por: Wang, Dong, et al.
Publicado: (2017)

The outcomes of endoscopic orbital decompression combined with fat decompression for thyroid-associated ophthalmopathy
por: Ye, Yunyan, et al.
Publicado: (2023)

Exploring the Role of SRC in Extraocular Muscle Fibrosis of the Graves’ Ophthalmopathy
por: Hao, Mingyu, et al.
Publicado: (2020)

Inflammatory swelling of the inferior oblique muscle in thyroid associated ophthalmopathy
por: Kakizaki, Hirohiko
Publicado: (2007)

Effect of Orbital Decompression on Corneal Topography in Patients with Thyroid Ophthalmopathy
por: Kim, Su Ah, et al.
Publicado: (2015)

Atypical Presentation of Hashimoto’s Disease in an Adolescent: Thyroid-Associated Ophthalmopathy
por: Kırmızıbekmez, Heves, et al.
Publicado: (2014)

PTX3: A Potential Biomarker in Thyroid Associated Ophthalmopathy
por: Mou, Pei, et al.
Publicado: (2018)

Treatment with bimatoprost for exophthalmos in patients with inactive thyroid-associated ophthalmopathy
por: Higashiyama, Tomoaki, et al.
Publicado: (2018)

Progress in the pathogenesis of thyroid-associated ophthalmopathy and new drug development
por: Huang, Yazhuo, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_v62qb678cs605v8d5ra90s5874